Original title: Exclusive | Fu Yanjie's official apology?
Chairman of Renhe Group: A special meeting has been held, and it is requested to deal with it as soon as possible
Sino-Singapore Jingwei, May 19 (Lin Wansi) On the 17th, the topic "Fu Yanjie's advertisement is accused of insulting women" was on the hot search.
As public opinion fermented, Fu Yanjie's customer service responded: "The company attaches great importance to this matter, the product has been removed from the shelves, and an internal investigation is underway. I am deeply sorry."
However, two days later, Renhe Pharmaceutical, the listed company behind Fu Yanjie, was not seen to apologize.
In response to this incident, on the afternoon of the 19th, Yang Wenlong, chairman of Renhe Group, the controlling shareholder of Renhe Pharmaceuticals, replied to Sino-Singapore Jingwei that the company now attaches great importance to this matter and is fully cooperating. "We also held a special meeting just now and asked the operation department to deal with it as soon as possible." .
When asked about the specific results, Yang Wenlong said that (Renhe) Group, as the controlling shareholder, did not know the specific situation.
According to the company's official website, Fuyanjie is a well-known brand product in the Chinese women's health care market.
Behind the Fuyanjie brand is Jiangxi Kangmei Medical and Health Products Co., Ltd., which is a wholly-owned subsidiary of Renhe Pharmaceutical.
According to public information, Yang Wenlong was the chairman and general manager of Kangmei Pharmaceutical.
(The opinions in this article are for reference only and do not constitute investment advice. Investment is risky, and you need to be cautious when entering the market.)